Generics - Mylan Laboratories


Current filters:

Mylan Laboratories

Popular Filters

76 to 96 of 96 results

FDA approves first generics of Roche osteo drug Boniva


The US Food and Drug Administration yesterday approved the first generic versions of Boniva (ibandronate)…

Anti-Arthritics/RheumaticsApotexBonivaGenericsMylan LaboratoriesNorth AmericaOrchid HealthcareRegulationRoche

Mylan gets OK for generic Crestor in Canada; Rottapharm deal looks dead


The Canadian subsidiary of US generic drugmaker Mylan (Nasdaq: MYL) has received approval from Health…

AstraZenecaCardio-vascularCrestorEuropeGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaPharmaceuticalRegulationRottapharm

Mylan gets tentative FDA approval for generic Epzicom


US generics major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Laboratories has received tentative…

Anti-viralsEpzicomGenericsGlaxoSmithKlineMylan LaboratoriesNorth AmericaPfizerRegulationViiV Healthcare

Mylan 4th-qtr profits beat expectations, but not sales


US generic drugs major Mylan (Nasdaq: MYL) yesterday posted financial results for the three months and…

FinancialGenericsMylan Laboratories

Mylan debuts innovative version of levetiracetam


US generic drugmaker Mylan (Nasdaq: MYL) says that its Mylan Institutional business has launched Levetiracetam…

GenericsKeppraLevetiracetamMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaUCB

Mylan confirms Actoplus patent challenge


US generic drugmaker Mylan (Nasdaq: MYL) has confirmed that it has been sued by Takeda Pharmaceutical…

AndrxDiabetesGenericsLegalMylan LaboratoriesNorth AmericaPatentsTakeda PharmaceuticalsWatson Pharmaceuticals

FDA OKs generic Ritalin for Actavis and Mylan’s Keppra


Iceland-based generic drugmaker Actavis says that it recently received approval from the US Food and…

ActavisGenericsKeppra XRMylan LaboratoriesNeurologicalRegulationRitalin LA

WHO OKs Mylan 'Second-Line-in-a-Box' HIV/AIDS treatments


US generic drugs major Mylan (Nasdaq: MYL) says its subsidiary Mylan Laboratories has received approval…

Anti-viralsGenericsMylan LaboratoriesRegulation

Management changes at Mylan, Transition Thera, Pfizer and ShangPharma


US generic drug major Mylan (Nasdaq: MYL) has announced the appointment of John Thievon as president…

GenericsManagementMylan LaboratoriesPharmaceuticalShangPharmaTransition Therapeutics

Mylan to acquire Pfizer generic respiratory delivery platform; challenge to GSK


US generic drug major Mylan (Nasdaq: MYL) has entered into an agreement with global pharma behemoth Pfizer…

Advair DiskusGenericsGlaxoSmithKlineLicensingMylan LaboratoriesPfizerPharmaceuticalRespiratory and PulmonarySeretide

Mylan settles with Warner Chilcott over Femcon


US generic drugmaker Mylan (Nasdaq: MYL) said yesterday that it, along with Famy Care, has entered into…

Femcon FeGenericsLegalMylan LaboratoriesNorth AmericaPatentsRespiratory and PulmonaryWarner Chilcott

Mylan enters settlement and license deal with Roche over Xeloda


US generic drugs giant Mylan (Nasdaq: MYL) says that it has entered into a settlement and license agreement…

GenericsLegalLicensingMylan LaboratoriesNorth AmericaOncologyRocheXeloda

Mylan’s Matrix gets tentative FDA approval for novel "co-packaged" version of HIV/AIDS drug


US generic drugmaker Mylan (Nasdaq: MYL) says that its Indian subsidiary Matrix Laboratories has received…

Anti-viralsGenericsMatrixMylan LaboratoriesNorth AmericaRegulation

Endo Pharma sues Mylan over Frova patent infringement


US generic drugmaker Mylan (Nasdaq: MYL) yesterday confirmed that the company and its subsidiary Mylan…

Endo PharmaceuticalsFrovaFrovatriptan SuccinateGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaRegulation

Alvogen launches new cancer generics in Romania; Mylan debuts Uroxatral copy in USA


US copy drugmaker Alvogen said last Friday that its subsidiary, Alvogen Romania, has launched generic…

AlvogenAromasinCamptoEuropeFemaraGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaOncologyUroxatral

76 to 96 of 96 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top